Hematopoietic stem cell transplantation is a life-saving therapy for many patients with
cancer, as well as patients with some nonmalignant hematologic disorders, such as aplastic …

Accompanied with the broad application of interventional therapy, the incidence of acute
kidney injury (AKI) has been recently increasing in clinical renal medicine. The …

Critically ill pediatric allogeneic hematopoietic cell transplant (HCT) patients may benefit
from early and aggressive interventions aimed at reversing the progression of multiorgan …

Background Acute kidney injury (AKI) is known to increase mortality in hospitalized cirrhotic
patients; therefore early identification is utmost significance. There are only a few studies …

Hematopoietic cell transplantation (HCT) is a common therapy for the treatment of neoplastic
and metabolic disorders, hematological diseases, and fatal immunological deficiencies …

Acute kidney injury (AKI) is a common complication in pediatric hematopoietic stem cell
transplantation (HSCT). Serum creatinine is an imprecise biomarker of AKI. We …

Hematopoietic stem cell transplantation (SCT) recipients are exposed to a large amount of
anti-cancer drugs, immunosuppressors, and irradiation during the peri-SCT period. Thus …

Introduction Cisplatin-associated acute kidney injury (AKI) is the major limitation to the use of
cisplatin-based chemotherapy regimens. Serum creatinine as a traditional marker did not …

Acute kidney injury (AKI) is highly prevalent whether the patients undergo myeloablative or
non-myeloablative hematopoietic cell transplantation (HCT); however, the pathogenesis and …

Acute graft-versus-host disease (aGVHD) and kidney injury are the major complications after
allogeneic hematopoietic stem cell transplantation (HSCT). Although the underlying …